ACP
GILD icon

Ashfield Capital Partners’s Gilead Sciences GILD Stock Holding History

Ashfield Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,982
Closed -$230K – 239
2018
Q3 		$230K Buy
+2,982
New +$225K 0.03% 237
2018
Q2 		– Sell
-2,820
Closed -$213K – 251
2018
Q1 		$213K Hold
2,820
– – 0.03% 241
2017
Q4 		$202K Hold
2,820
– – 0.03% 249
2017
Q3 		$228K Sell
2,820
-715
-20% -$54.7K 0.03% 234
2017
Q2 		$250K Sell
3,535
-26,227
-88% -$1.75M 0.03% 230
2017
Q1 		$2.02M Sell
29,762
-32,429
-52% -$2.28M 0.28% 96
2016
Q4 		$4.45M Sell
62,191
-40,880
-40% -$3.04M 0.44% 70
2016
Q3 		$8.15M Sell
103,071
-36,232
-26% -$2.94M 0.67% 50
2016
Q2 		$11.6M Sell
139,303
-37,221
-21% -$3.3M 0.93% 40
2016
Q1 		$16.2M Sell
176,524
-1,694
-1% -$153K 1.17% 25
2015
Q4 		$18M Sell
178,218
-91,077
-34% -$9.48M 1.23% 27
2015
Q3 		$26.4M Buy
269,295
+178,410
+196% +$19.8M 1.7% 16
2015
Q2 		$10.6M Buy
90,885
+15,732
+21% +$1.72M 0.58% 51
2015
Q1 		$7.38M Buy
75,153
+13,863
+23% +$1.41M 0.39% 61
2014
Q4 		$5.78M Sell
61,290
-289
-0.5% -$29.9K 0.28% 69
2014
Q3 		$6.55M Buy
61,579
+768
+1% +$75.2K 0.32% 69
2014
Q2 		$5.04M Buy
60,811
+881
+1% +$68.6K 0.24% 77
2014
Q1 		$4.25M Buy
59,930
+2,393
+4% +$188K 0.2% 80
2013
Q4 		$4.32M Buy
57,537
+19,528
+51% +$1.36M 0.21% 78
2013
Q3 		$2.39M Buy
38,009
+3,552
+10% +$212K 0.12% 99
2013
Q2 		$1.77M Buy
+34,457
New +$1.8M 0.1% 113

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ashfield Capital Partners's GILD Position: Q4 2018 in Review

Ashfield Capital Partners sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 2,982 shares — an estimated $230K sold.

Ashfield Capital Partners first reported a position in GILD in Q2 2013 and held it in 21 quarters. The position peaked at $26.4M in Q3 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Ashfield Capital Partners reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Ashfield Capital Partners sold 2,982 Gilead Sciences shares in Q4 2018, an estimated $230K.
  • Ashfield Capital Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 21 quarters.
  • Ashfield Capital Partners's Gilead Sciences position peaked at $26.4M in Q3 2015.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Ashfield Capital Partners's 13F filing for Q4 2018, filed 13 Feb 2019.